anti-CDKN1C antibody product blog
Tags: Antibody; Polyclonal Antibody; CDKN1C; anti-CDKN1C antibody;
The CDKN1C cdkn1c (Catalog #MBS150056) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The CDKN1C Antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s CDKN1C can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB), Immunofluorescence (IF).CDKN1C antibody can be used for detection of CDKN1C by Western blot at 1 - 2 mug/mL. For immunofluorescence start at 20 mug/mL. Researchers should empirically determine the suitability of the CDKN1C cdkn1c for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The CDKN1C cdkn1c product has the following accession number(s) (GI #4557441) (NCBI Accession #NP_000067) (Uniprot Accession #P49918). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the CDKN1C Antibody with the following immunoassay(s):
Western Blot (WB) (Western blot analysis of CDKN1C in 293 cell lysate with CDKN1C antibody at (A) 1 and (B) 2 μg/mL.)
Immunofluorescence (IF) (Immunofluorescence of CDKN1C in 293 cells with CDKN1C antibody at 20 μg/mL.)
CDKN1C Antibody: The cyclin-dependent kinase inhibitor 1C (CDKN1C), also known as p57KIP2, is a tight-binding, strong inhibitor of several G1 cyclin/CDK complexes and a negative regulator of cell proliferation. Mutations in this gene are implicated in sporadic cancers and Beckwith-Wiedemann syndrome, a cancer-predisposing syndrome, suggesting that this gene is a tumor suppressor candidate. CDKN1C is widely expressed during organogenesis with its expression declining after maturity. It is part of the CIP/KIP family of cyclin-dependent inhibitors (CKIs) which also includes CDKN1A and CDKN1B.
Conjugate: Unconjugated
Immunogen: CDKN1C antibody was raised against a 17 amino acid synthetic peptide near the amino terminus of human CDKN1C.
Buffer: CDKN1C Antibody is supplied in PBS containing 0.02% sodium azide. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CDKN1C are readily searchable from our website. Different antibodies against the same target such as CDKN1C may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.